A drug that can halve the risk of developing breast cancer in post-menopausal women has been approved for use in the UK. This drug, called anastrozole, could benefit an estimated 289,000 women in the UK who are at increased ...
Nov 9, 2023
0
0
Teens from low-income families experiencing food insecurity are developing the most common form of liver disease twice as often as those who have easier access to food, likely because they rely on low-cost, ultra-processed ...
Nov 7, 2023
0
1
An international clinical trial involving Birmingham Professor Phil Newsome identified a promising target for patients with non-alcoholic steatohepatitis (NASH), as reported in a paper published yesterday (Nov. 6) in Nature ...
Nov 7, 2023
0
41
Fatty liver diseases (FLD) have become a significant health concern worldwide, affecting millions. The two most common types of FLD are non-alcoholic fatty liver disease (NAFLD) and alcoholic-associated liver disease (ALD).
Nov 6, 2023
0
0
A research team has announced a new genetic classification system for gastric cancer by a multicenter study with the University of Texas MD Anderson Cancer Center. This research could lay the foundation for personalized gastric ...
Nov 6, 2023
0
0
Gene therapy adeno-associated viruses (AAVs)—viruses that can be engineered to deliver DNA to target cells—are unlikely to cause cancer-triggering insertions in humans or monkeys and may contribute to long-term efficacy, ...
Nov 6, 2023
0
17
Pregnant individuals living in states with tighter constraints on abortion access were found to be more likely to have cardiovascular complications, like hypertension, compared to peers in states with less abortion access ...
Nov 6, 2023
0
0
Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals' genetic ancestry. PKU causes an amino acid—called phenylalanine (Phe)—to build ...
Nov 2, 2023
0
50
Professor Chai Hong Rim of the Department of Radiation Oncology, Korea University's Ansan Hospital, along with student Jungsue Lee and Sooyeon Kim of the College of Medicine, Korea University, proved the efficacy of active ...
Nov 2, 2023
0
0
Surgical removal of parts of the liver remains the only curative approach for patients with liver-specific cancer. An international team led by Patrick Starlinger from MedUni Vienna has developed a score that provides an ...
Nov 2, 2023
0
0
